Literature DB >> 35882951

The role of PSA density in the MRI pathway for prostate cancer diagnostics.

Hannes Cash1,2, Martin Schostak3.   

Abstract

Entities:  

Year:  2022        PMID： 35882951     DOI： 10.1038/s41391-022-00579-6

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.455


× No keyword cloud information.
  9 in total

1.  Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.

Authors:  Dominik Deniffel; Gerard M Healy; Xin Dong; Sangeet Ghai; Emmanuel Salinas-Miranda; Neil Fleshner; Robert Hamilton; Girish Kulkarni; Ants Toi; Theodorus van der Kwast; Alexandre Zlotta; Antonio Finelli; Nathan Perlis; Masoom A Haider
Journal:  Radiology       Date:  2021-05-25       Impact factor: 11.105

2.  Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Authors:  Olivier Rouvière; Philippe Puech; Raphaële Renard-Penna; Michel Claudon; Catherine Roy; Florence Mège-Lechevallier; Myriam Decaussin-Petrucci; Marine Dubreuil-Chambardel; Laurent Magaud; Laurent Remontet; Alain Ruffion; Marc Colombel; Sébastien Crouzet; Anne-Marie Schott; Laurent Lemaitre; Muriel Rabilloud; Nicolas Grenier
Journal:  Lancet Oncol       Date:  2018-11-21       Impact factor: 41.316

3.  Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD).

Authors:  Ugo Giovanni Falagario; Ivan Jambor; Anna Lantz; Otto Ettala; Armando Stabile; Pekka Taimen; Hannu J Aronen; Juha Knaapila; Ileana Montoya Perez; Giorgio Gandaglia; Nicola Fossati; Alberto Martini; Vito Cucchiara; Wolfgang Picker; Erik Haug; Parita Ratnani; Kenneth Haines; Sara Lewis; Nair Sujit; Oscar Selvaggio; Francesca Sanguedolce; Luca Macarini; Luigi Cormio; Tobias Nordström; Ash Tewari; Alberto Briganti; Peter J Boström; Giuseppe Carrieri
Journal:  Eur Urol Oncol       Date:  2020-09-21

Review 4.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Roderick C N van den Bergh; Erik Briers; Thomas Van den Broeck; Marcus G Cumberbatch; Maria De Santis; Stefano Fanti; Nicola Fossati; Giorgio Gandaglia; Silke Gillessen; Nikos Grivas; Jeremy Grummet; Ann M Henry; Theodorus H van der Kwast; Thomas B Lam; Michael Lardas; Matthew Liew; Malcolm D Mason; Lisa Moris; Daniela E Oprea-Lager; Henk G van der Poel; Olivier Rouvière; Ivo G Schoots; Derya Tilki; Thomas Wiegel; Peter-Paul M Willemse; Philip Cornford
Journal:  Eur Urol       Date:  2020-11-07       Impact factor: 20.096

5.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

6.  Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data.

Authors:  Sebastiaan Remmers; Veeru Kasivisvanathan; Jan F M Verbeek; Caroline M Moore; Monique J Roobol
Journal:  Eur Urol Open Sci       Date:  2021-12-15

7.  The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.

Authors:  Thomas Stonier; Nick Simson; Taimur Shah; Niyati Lobo; Tarik Amer; Su-Min Lee; Edward Bass; Edwin Chau; Alistair Grey; Neil McCartan; Peter Acher; Imran Ahmad; Nimalan Arumainayagam; Dominic Brown; Alex Chapman; Deborah Elf; Thomas Hartington; Ibrahim Ibrahim; Hing Leung; Sidath Liyanage; Catherine Lovegrove; Theo Malthouse; Bilal Mateen; Kiki Mistry; Iain Morrison; Sarika Nalagatla; Raj Persad; Alvan Pope; Heminder Sokhi; Hira Syed; Sergey Tadtayev; Meera Tharmaratnam; Ahmed Qteishat; Saiful Miah; Mark Emberton; Caroline Moore; Tom Walton; Ben Eddy; Hashim U Ahmed
Journal:  Eur Urol Focus       Date:  2020-10-10

8.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

9.  Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models.

Authors:  Vasilis Stavrinides; Georgios Papageorgiou; Dominic Danks; Francesco Giganti; Nora Pashayan; Bruce Trock; Alex Freeman; Yipeng Hu; Hayley Whitaker; Clare Allen; Alex Kirkham; Shonit Punwani; Geoffrey Sonn; Dean Barratt; Mark Emberton; Caroline M Moore
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-05-06       Impact factor: 5.554
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.